Glaukos Corp. (GKOS)
135.27
+1.85
(+1.39%)
USD |
NYSE |
May 06, 16:00
135.05
-0.22
(-0.16%)
Pre-Market: 08:25
Glaukos Cash from Investing (Quarterly) : 10.50M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Intuitive Surgical, Inc. | -914.50M |
| Globus Medical, Inc. | -111.45M |
| Insulet Corp. | -- |
| iRhythm Holdings, Inc. | 30.22M |
| Plus Therapeutics, Inc. | -1.077M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -12.53M |
| Cash from Financing (Quarterly) | 15.77M |
| Free Cash Flow | -35.09M |
| Free Cash Flow Per Share (Quarterly) | -0.2841 |
| Free Cash Flow to Equity (Quarterly) | -13.00M |
| Free Cash Flow to Firm (Quarterly) | -15.33M |
| Free Cash Flow Yield | -0.45% |